China Biosimilars Industry 2018 Market Research Report

Published: Feb, 2018 | Pages: 97 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global Biosimilars market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Biosimilars development status and future trend in China, focuses on top players in China, also splits Biosimilars by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Pfizer
    Sandoz International GmbH
    Teva Pharmaceuticals Industries
    Amgen Inc
    Biocon
    Dr. Reddy's Laboratories
    F. Hoffmann-La Roche
    Celltrion
    Samsung Bioepis

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
    Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
    Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
    Peptides (Glucagon, Calcitonin)

On the basis of the end users/application, this report covers
    Oncology
    Blood Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

China Biosimilars Market Research Report 2017
1 Biosimilars Overview
    1.1 Product Overview and Scope of Biosimilars
    1.2 Classification of Biosimilars by Product Category
        1.2.1 China Biosimilars Sales (K MT) Comparison by Type (2012-2022)
        1.2.2 China Biosimilars Sales (K MT) Market Share by Type in 2016
        1.2.3 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
        1.2.4 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
        1.2.5 Peptides (Glucagon, Calcitonin)
    1.3 China Biosimilars Market by Application/End Users
        1.3.1 China Biosimilars Sales (K MT) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Oncology
        1.3.3 Blood Disorders
    1.4 China Biosimilars Market by Region
        1.4.1 China Biosimilars Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Biosimilars Status and Prospect (2012-2022)
        1.4.3 East China Biosimilars Status and Prospect (2012-2022)
        1.4.4 Southwest China Biosimilars Status and Prospect (2012-2022)
        1.4.5 Northeast China Biosimilars Status and Prospect (2012-2022)
        1.4.6 North China Biosimilars Status and Prospect (2012-2022)
        1.4.7 Central China Biosimilars Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Biosimilars (2012-2022)
        1.5.1 China Biosimilars Sales (K MT) and Growth Rate (%)(2012-2022)
        1.5.2 China Biosimilars Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Biosimilars Market Competition by Players/Manufacturers
    2.1 China Biosimilars Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Biosimilars Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Biosimilars Average Price (USD/MT) by Players/Manufacturers (2012-2017)
    2.4 China Biosimilars Market Competitive Situation and Trends
        2.4.1 China Biosimilars Market Concentration Rate
        2.4.2 China Biosimilars Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Biosimilars Manufacturing Base Distribution, Sales Area, Product Types

3 China Biosimilars Sales and Revenue by Region (2012-2017)
    3.1 China Biosimilars Sales (K MT) and Market Share by Region (2012-2017)
    3.2 China Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Biosimilars Price (USD/MT) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Biosimilars Sales (K MT) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Biosimilars Price (USD/MT) by Type (2012-2017)
    4.4 China Biosimilars Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Biosimilars Sales (K MT) and Market Share by Application (2012-2017)
    5.2 China Biosimilars Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Biosimilars Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Biosimilars Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sandoz International GmbH
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Biosimilars Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sandoz International GmbH Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Teva Pharmaceuticals Industries
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Biosimilars Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Teva Pharmaceuticals Industries Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Amgen Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Biosimilars Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Amgen Inc Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Biocon
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Biosimilars Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Biocon Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Dr. Reddy's Laboratories
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Biosimilars Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 F. Hoffmann-La Roche
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Biosimilars Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 F. Hoffmann-La Roche Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Celltrion
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Biosimilars Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Celltrion Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Samsung Bioepis
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Biosimilars Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Samsung Bioepis Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview

7 Biosimilars Manufacturing Cost Analysis
    7.1 Biosimilars Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Biosimilars

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Biosimilars Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Biosimilars Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Biosimilars Sales (K MT), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Biosimilars Sales (K MT) Forecast by Type (2017-2022)
    11.3 China Biosimilars Sales (K MT) Forecast by Application (2017-2022)
    11.4 China Biosimilars Sales (K MT) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List

List of Tables and Figures

    Figure Global and China Market Size (Million USD) Comparison (2012-2022)
    Table Biosimilars Sales (K MT) and Revenue (Million USD) Market Split by Product Type
    Table Biosimilars Sales (K MT) by Application (2016-2022)
    Figure Product Picture of Biosimilars
    Table China Biosimilars Sales (K MT) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
    Figure China Biosimilars Sales Volume Market Share by Types in 2016
    Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
    Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Product Picture
    Figure Peptides (Glucagon, Calcitonin) Product Picture
    Figure China Biosimilars Sales (K MT) Comparison by Application (2012-2022)
    Figure China Sales Market Share (%) of Biosimilars by Application in 2016
    Figure Oncology Examples
    Table Key Downstream Customer in Oncology
    Figure Blood Disorders Examples
    Table Key Downstream Customer in Blood Disorders
    Figure South China Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
    Figure East China Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southwest China Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Northeast China Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
    Figure North China Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Central China Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
    Figure China Biosimilars Sales (K MT) and Growth Rate (%)(2012-2022)
    Figure China Biosimilars Revenue (Million USD) and Growth Rate (%)(2012-2022)
    Table China Biosimilars Sales of Key Players/Manufacturers (2012-2017)
    Table China Biosimilars Sales Share (%) by Players/Manufacturers (2012-2017)
    Figure 2016 China Biosimilars Sales Share (%) by Players/Manufacturers
    Figure 2017 China Biosimilars Sales Share (%) by Players/Manufacturers
    Table China Biosimilars Revenue by Players/Manufacturers (2012-2017)
    Table China Biosimilars Revenue Market Share (%) by Players/Manufacturers (2012-2017)
    Figure 2016 China Biosimilars Revenue Market Share (%) by Players/Manufacturers
    Figure 2017 China Biosimilars Revenue Market Share (%) by Players/Manufacturers
    Table China Market Biosimilars Average Price of Key Players/Manufacturers (2012-2017)
    Figure China Market Biosimilars Average Price of Key Players/Manufacturers in 2016
    Figure China Biosimilars Market Share of Top 3 Players/Manufacturers
    Figure China Biosimilars Market Share of Top 5 Players/Manufacturers
    Table China Players/Manufacturers Biosimilars Manufacturing Base Distribution and Sales Area
    Table China Players/Manufacturers Biosimilars Product Category
    Table China Biosimilars Sales (K MT) by Regions (2012-2017)
    Table China Biosimilars Sales Share (%) by Regions (2012-2017)
    Figure China Biosimilars Sales Share (%) by Regions (2012-2017)
    Figure China Biosimilars Sales Market Share (%) by Regions in 2016
    Table China Biosimilars Revenue (Million USD) and Market Share by Regions (2012-2017)
    Table China Biosimilars Revenue Market Share (%) by Regions (2012-2017)
    Figure China Biosimilars Revenue Market Share (%) by Regions (2012-2017)
    Figure China Biosimilars Revenue Market Share (%) by Regions in 2016
    Table China Biosimilars Price (USD/MT) by Regions (2012-2017)
    Table China Biosimilars Sales (K MT) by Type (2012-2017)
    Table China Biosimilars Sales Share (%) by Type (2012-2017)
    Figure China Biosimilars Sales Share (%) by Type (2012-2017)
    Figure China Biosimilars Sales Market Share (%) by Type in 2016
    Table China Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
    Table China Biosimilars Revenue Market Share (%) by Type (2012-2017)
    Figure Revenue Market Share of Biosimilars by Type (2012-2017)
    Figure Revenue Market Share of Biosimilars by Type in 2016
    Table China Biosimilars Price (USD/MT) by Types (2012-2017)
    Figure China Biosimilars Sales Growth Rate (%) by Type (2012-2017)
    Table China Biosimilars Sales (K MT) by Applications (2012-2017)
    Table China Biosimilars Sales Market Share (%) by Applications (2012-2017)
    Figure China Biosimilars Sales Market Share (%) by Application (2012-2017)
    Figure China Biosimilars Sales Market Share (%) by Application in 2016
    Table China Biosimilars Sales Growth Rate (%) by Application (2012-2017)
    Figure China Biosimilars Sales Growth Rate (%) by Application (2012-2017)
    Table Pfizer Biosimilars Basic Information List
    Table Pfizer Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Pfizer Biosimilars Sales (K MT) and Growth Rate (%)(2012-2017)
    Figure Pfizer Biosimilars Sales Market Share (%) in China (2012-2017)
    Figure Pfizer Biosimilars Revenue Market Share (%) in China (2012-2017)
    Table Sandoz International GmbH Biosimilars Basic Information List
    Table Sandoz International GmbH Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Sandoz International GmbH Biosimilars Sales (K MT) and Growth Rate (%)(2012-2017)
    Figure Sandoz International GmbH Biosimilars Sales Market Share (%) in China (2012-2017)
    Figure Sandoz International GmbH Biosimilars Revenue Market Share (%) in China (2012-2017)
    Table Teva Pharmaceuticals Industries Biosimilars Basic Information List
    Table Teva Pharmaceuticals Industries Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Teva Pharmaceuticals Industries Biosimilars Sales (K MT) and Growth Rate (%)(2012-2017)
    Figure Teva Pharmaceuticals Industries Biosimilars Sales Market Share (%) in China (2012-2017)
    Figure Teva Pharmaceuticals Industries Biosimilars Revenue Market Share (%) in China (2012-2017)
    Table Amgen Inc Biosimilars Basic Information List
    Table Amgen Inc Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Amgen Inc Biosimilars Sales (K MT) and Growth Rate (%)(2012-2017)
    Figure Amgen Inc Biosimilars Sales Market Share (%) in China (2012-2017)
    Figure Amgen Inc Biosimilars Revenue Market Share (%) in China (2012-2017)
    Table Biocon Biosimilars Basic Information List
    Table Biocon Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Biocon Biosimilars Sales (K MT) and Growth Rate (%)(2012-2017)
    Figure Biocon Biosimilars Sales Market Share (%) in China (2012-2017)
    Figure Biocon Biosimilars Revenue Market Share (%) in China (2012-2017)
    Table Dr. Reddy's Laboratories Biosimilars Basic Information List
    Table Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Dr. Reddy's Laboratories Biosimilars Sales (K MT) and Growth Rate (%)(2012-2017)
    Figure Dr. Reddy's Laboratories Biosimilars Sales Market Share (%) in China (2012-2017)
    Figure Dr. Reddy's Laboratories Biosimilars Revenue Market Share (%) in China (2012-2017)
    Table F. Hoffmann-La Roche Biosimilars Basic Information List
    Table F. Hoffmann-La Roche Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure F. Hoffmann-La Roche Biosimilars Sales (K MT) and Growth Rate (%)(2012-2017)
    Figure F. Hoffmann-La Roche Biosimilars Sales Market Share (%) in China (2012-2017)
    Figure F. Hoffmann-La Roche Biosimilars Revenue Market Share (%) in China (2012-2017)
    Table Celltrion Biosimilars Basic Information List
    Table Celltrion Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Celltrion Biosimilars Sales (K MT) and Growth Rate (%)(2012-2017)
    Figure Celltrion Biosimilars Sales Market Share (%) in China (2012-2017)
    Figure Celltrion Biosimilars Revenue Market Share (%) in China (2012-2017)
    Table Samsung Bioepis Biosimilars Basic Information List
    Table Samsung Bioepis Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2012-2017)
    Figure Samsung Bioepis Biosimilars Sales (K MT) and Growth Rate (%)(2012-2017)
    Figure Samsung Bioepis Biosimilars Sales Market Share (%) in China (2012-2017)
    Figure Samsung Bioepis Biosimilars Revenue Market Share (%) in China (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Biosimilars
    Figure Manufacturing Process Analysis of Biosimilars
    Figure Biosimilars Industrial Chain Analysis
    Table Raw Materials Sources of Biosimilars Major Players/Manufacturers in 2016
    Table Major Buyers of Biosimilars
    Table Distributors/Traders List
    Figure China Biosimilars Sales (K MT) and Growth Rate (%) Forecast (2017-2022)
    Figure China Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure China Biosimilars Price (USD/MT) Trend Forecast (2017-2022)
    Table China Biosimilars Sales (K MT) Forecast by Type (2017-2022)
    Figure China Biosimilars Sales (K MT) Forecast by Type (2017-2022)
    Figure China Biosimilars Sales Volume Market Share Forecast by Type in 2022
    Table China Biosimilars Sales (K MT) Forecast by Application (2017-2022)
    Figure China Biosimilars Sales Volume Market Share Forecast by Application (2017-2022)
    Figure China Biosimilars Sales Volume Market Share Forecast by Application in 2022
    Table China Biosimilars Sales (K MT) Forecast by Regions (2017-2022)
    Table China Biosimilars Sales Volume Share Forecast by Regions (2017-2022)
    Figure China Biosimilars Sales Volume Share Forecast by Regions (2017-2022)
    Figure China Biosimilars Sales Volume Share Forecast by Regions in 2022
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources